MedlinePlus one-way links to health info within the Countrywide Institutes of Wellbeing and other federal government organizations. MedlinePlus also inbound links to wellbeing data from non-federal government Websites. See our disclaimer about exterior back links and our top quality guidelines.
pentobarbital will minimize the level or result of ziprasidone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Not known.
pentobarbital will decrease the extent or result of dapsone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unidentified.
pentobarbital will reduce the level or influence of tolterodine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
Keep an eye on Closely (1)pentobarbital will decrease the level or influence of gefitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will decrease the extent or impact of acalabrutinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
Check Carefully (one)pentobarbital will decrease the level or impact of tofacitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Loss of, or lessened response to tofacitinib could arise when coadministered with powerful CYP3A4 inducers
Using barbiturates as sedatives inside the postoperative surgical interval and as adjuncts to most cancers chemotherapy is very well set up
pentobarbital will lower the extent or effect of dutasteride by influencing hepatic/intestinal enzyme CYP3A4 what does nembutal do metabolism. Insignificant/Significance Mysterious.
pentobarbital will lessen the extent or effect of celecoxib by affecting hepatic enzyme CYP2C9/10 metabolism. Insignificant/Significance Unknown.
pentobarbital will minimize the extent or outcome of piroxicam by influencing hepatic enzyme CYP2C9/ten metabolism. Minor/Importance Unfamiliar.
pentobarbital will lower the extent or effect of levamlodipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the extent or effect of lonafarnib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is a delicate CYP3A4 substrate. Coadministration with powerful or moderate CYP3A4 inducers is contraindicated.
pentobarbital will decrease the extent or influence of doravirine by affecting hepatic/intestinal enzyme CYP3A4 metabolism.